MHTF Advisory Group member Justus Hofmeyr and colleagues have published a review in the Bulletin of the World Health Organization of the evidence on the effects of misoprostol for the prevention and treatment of postpartum hemorrhage. The review includes 46 randomized trials with more than 40,000 participants. They concluded that further research is needed to more accurately assess the potential beneficial and harmful effects of misoprostol and to determine the smallest safe, effective dose. To read this review, click here.
Let us know if this was useful, rate this article here.